New patent for Glaxo Grp drug ADVAIR HFABy DrugPatentWatch – Make Better Decisions / April 14, 2024 Annual Drug Patent Expirations for ADVAIR+HFA Advair Hfa is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from three suppliers. There is…Source